An anticoagulant RNA aptamer that inhibits proteinase-cofactor interactions within prothrombinase.
The interaction of factor Xa with factor Va on membranes to form prothrombinase profoundly increases the rate of the proteolytic conversion of prothrombin to thrombin. We present the characterization of an RNA aptamer (RNA(11F7t)) selected from a combinatorial library based on its ability to bind factor Xa. We show that RNA(11F7t) inhibits thrombin formation catalyzed by prothrombinase without obscuring the active site of Xa within the enzyme complex. Selective inhibition of protein substrate cleavage arises from the ability of the aptamer to bind to factor Xa and exclude interactions between the proteinase and cofactor within prothrombinase. Competition for enzyme complex assembly results from the binding of RNA(11F7t) to factor Xa with nanomolar affinity in a Ca(2+)-dependent interaction. RNA(11F7t) binds equivalently to the zymogen factor X as well as derivatives lacking gamma-carboxyglutamic acid residues. We suggest that the ability of RNA(11F7t) to compete for the Xa-Va interaction with surprisingly high affinity likely reflects a significant contribution from its ability to indirectly impact regions of Xa that participate in the proteinase-cofactor interaction. Thus, despite the complexity of the macromolecular interactions that underlie the assembly of prothrombinase, efficient inhibition of enzyme complex assembly and thrombin formation can be achieved by tight binding ligands that target factor Xa in a discrete manner.
Buddai
Sai K
SK
Joseph Stokes Research Institute, Children's Hospital of Philadelphia, Pennsylvania 19104, USA.
Layzer
Juliana M
JM
Lu
Genmin
G
Rusconi
Christopher P
CP
Sullenger
Bruce A
BA
Monroe
Dougald M
DM
Krishnaswamy
Sriram
S
D000925:Anticoagulants / Q000737:chemistry* / Q000378:metabolism; D052157:Aptamers, Nucleotide / Q000737:chemistry* / Q000378:metabolism; D002118:Calcium / Q000737:chemistry / Q000378:metabolism; D005165:Factor V / Q000037:antagonists & inhibitors* / Q000737:chemistry* / Q000378:metabolism; D015951:Factor Xa / Q000737:chemistry* / Q000378:metabolism; D065427:Factor Xa Inhibitors; D006801:Humans; D011485:Protein Binding / Q000187:drug effects; D013917:Thrombin / Q000737:chemistry* / Q000378:metabolism
D000925:Anticoagulants; D052157:Aptamers, Nucleotide; D065427:Factor Xa Inhibitors; C022475:prothrombinase complex; D005165:Factor V; D013917:Thrombin; D015951:Factor Xa; D002118:Calcium